Berretta M - Search Results

1

Decision criteria for rational selection of homogeneous genotyping platforms for pharmacogenomics testing in clinical diagnostics.

Di Francia R, Frigeri F, Berretta M, Cecchin E, Orlando C, Pinto A, Pinzani P. Di Francia R, et al. Among authors: berretta m. Clin Chem Lab Med. 2010 Apr;48(4):447-59. doi: 10.1515/CCLM.2010.112. Clin Chem Lab Med. 2010. PMID: 20192881 Review.

2

Molecular diagnostics for pharmacogenomic testing of fluoropyrimidine based-therapy: costs, methods and applications.

Di Francia R, Berretta M, Catapano O, Canzoniero LM, Formisano L. Di Francia R, et al. Among authors: berretta m. Clin Chem Lab Med. 2011 Jul;49(7):1105-11. doi: 10.1515/CCLM.2011.181. Epub 2011 Apr 20. Clin Chem Lab Med. 2011. PMID: 21504372 Review.

3

Genetic variants influencing fluoropyrimidine based-therapy and available methods to detect them.

Di Francia R, Cimino L, Berretta M. Di Francia R, et al. Among authors: berretta m. Eur Rev Med Pharmacol Sci. 2012 Mar;16(3):285-98. Eur Rev Med Pharmacol Sci. 2012. PMID: 22530343 Review.

4

Knowledge and skills needs for health professions about pharmacogenomics testing field.

Di Francia R, Valente D, Catapano O, Rupolo M, Tirelli U, Berretta M. Di Francia R, et al. Among authors: berretta m. Eur Rev Med Pharmacol Sci. 2012 Jun;16(6):781-8. Eur Rev Med Pharmacol Sci. 2012. PMID: 22913211 Review.

5

Pharmacogenomics panel test for prevention toxicity in patient who receive Fluoropirimidine/Oxaliplatin-based therapy.

Di Francia R, Siesto RS, Valente D, Spart D, Berretta M. Di Francia R, et al. Among authors: berretta m. Eur Rev Med Pharmacol Sci. 2012 Sep;16(9):1211-7. Eur Rev Med Pharmacol Sci. 2012. PMID: 23047504 Free article. Review.

6

Antiblastic treatment, for solid tumors, during pregnancy: a crucial decision.

Berretta M, Di Francia R, Lleshi A, De Paoli P, Li Volti G, Bearz A, Del Pup L, Tirelli U, Michieli M. Berretta M, et al. Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2 Suppl):1S-19S. doi: 10.1177/03946320120250s201. Int J Immunopathol Pharmacol. 2012. PMID: 23092516 Free article. Review.

7

Evaluation of genotyping methods and the relative cost of pharmacogenomics.

De Monaco A, Berretta M, Pugliese S, Valente D, Ciaffarafa S, Di Francia R. De Monaco A, et al. Among authors: berretta m. Eur Rev Med Pharmacol Sci. 2014;18(14):2084-7. Eur Rev Med Pharmacol Sci. 2014. PMID: 25027351 Free article.

8

Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma.

Berretta M, Di Francia R, Martella L, Tirelli U. Berretta M, et al. Eur Rev Med Pharmacol Sci. 2015 Apr;19(7):1117-8. Eur Rev Med Pharmacol Sci. 2015. PMID: 25912566 Free article. No abstract available.

9

Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma.

Berretta M, Di Francia R, Tirelli U. Berretta M, et al. Eur Rev Med Pharmacol Sci. 2015;19(14):2521-2. Eur Rev Med Pharmacol Sci. 2015. PMID: 26221876 Free article. No abstract available.

10

Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity.

Berretta M, Martellotta F, Di Francia R, Spina M, Vaccher E, Balestreri L, Borsatti E, Bearz A, De Paoli P, Tirelli U. Berretta M, et al. Eur Rev Med Pharmacol Sci. 2015 Oct;19(19):3619-34. Eur Rev Med Pharmacol Sci. 2015. PMID: 26502852 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

413 results

Search Page

Filters